Pantry, Shara N, Medveczky, Maria M, Arbuckle, Jesse H et al. · Journal of medical virology · 2013 · DOI
Some people inherit a virus called HHV-6 that becomes integrated into their DNA from birth. This study found that a small group of patients with this inherited virus also had active infections from a related but separate HHV-6 strain, and these patients experienced neurological symptoms including long-term fatigue. When treated with antiviral medications, the active viral infection was suppressed, suggesting the medication could help control symptoms.
This research identifies a potential viral mechanism contributing to neurological symptoms and persistent fatigue in a subset of patients. The finding that some individuals carry inherited HHV-6 while also being infected with an active exogenous strain, and that antivirals can suppress replication, suggests a possible biomarker and treatment target relevant to ME/CFS research. Understanding the relationship between persistent viral infections and long-term fatigue could advance diagnostic and therapeutic strategies.
This study does not prove that HHV-6 causes ME/CFS or that antiviral treatment will benefit all ME/CFS patients. The small sample size (four treated cases) and case-control design cannot establish causation or the prevalence of this condition in the broader ME/CFS population. Correlation between CIHHV-6, exogenous infection, and fatigue does not demonstrate that the virus is the primary driver of disease.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →